Impact of Treatment on Large Intestine Histology in Chronic Hepatitis C Patients
Author Information
Author(s): Pantazis Konstantinos D., Elefsiniotis Ioannis S., Papaioannou Dimitrios, Brokalaki Hero, Bonatsos Gerasimos, Mavrogiannis Christos
Primary Institution: University of Athens
Hypothesis
Does pegylated-interferon alpha plus ribavirin treatment affect the large intestine histology of chronic hepatitis C patients?
Conclusion
The study suggests that the treatment does not significantly affect the large intestine histology of treated patients.
Supporting Evidence
- Patients exhibited no significant difference in bowel inflammatory infiltration compared to controls.
- 25% of CHC patients showed architectural disorder and decreased mucus production.
- 16.7% of CHC patients had Paneth cells present compared to none in controls.
Takeaway
Doctors wanted to see if a specific treatment for hepatitis C changed the way the intestines looked. They found it didn't really change much, even though some patients had tummy troubles.
Methodology
The study involved 24 treatment-naïve chronic hepatitis C patients who were treated with pegylated-interferon alpha and ribavirin for 24 weeks, with biopsies taken before and after treatment.
Limitations
The small sample size limits the generalizability of the findings.
Participant Demographics
14 males and 10 females, average age 37.04 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website